Cormorant Asset Management

Cormorant Asset Management is a Boston-based investment manager and venture investor founded in 2013 that focuses on life sciences and healthcare. The firm invests across public and private markets, primarily in biotechnology and pharmaceutical companies, using a long-term, fundamental research approach grounded in scientific and therapeutic analysis. It backs later-stage private financings and has acted as a co-lead investor, making it relevant for biopharmaceutical, oncology, immunology, neurology and medical device companies seeking specialist healthcare capital in the United States, Germany or Switzerland.